Dr. Sejal Saglani, BSc (Hons), MBChB, MD, FRCPCH, FERS, FMedSci, is Professor of Paediatric Respiratory Medicine at the National Heart & Lung Institute, Faculty of Medicine, Imperial College London. She leads the Paediatric Severe Asthma Group at the National Heart & Lung Institute and is Director of the Centre for Paediatrics & Child Health at Imperial College London. She is also a Consultant in Paediatric Respiratory Medicine at the Royal Brompton Hospital and a member of the Paediatric Difficult Asthma Team.
Professor Saglani qualified in medicine at the University of Leicester and completed specialist training in paediatric respiratory medicine. Supported by Asthma UK, she undertook postgraduate research at the National Heart & Lung Institute, focusing on severe wheeze and asthma in infants and pre-school children, for which she was awarded the NHLI Best Thesis Prize.
Following her clinical training, she held a British Lung Foundation Research Fellowship and subsequently a Wellcome Intermediate Clinical Fellowship investigating early-life mechanisms underlying pre-school wheeze and asthma. She has since received an MRC New Investigator Award and an NIHR Career Development Fellowship, and currently leads an NIHR-funded clinical trial evaluating novel treatments for childhood severe asthma.
Professor Saglani’s clinical and research interests include the management of pre-school wheeze and difficult asthma, predictors of progression to school-age asthma, and the identification of novel therapies for severe childhood asthma. She has established a translational research programme integrating pre-clinical models, paediatric airway samples, and interventional clinical trials. In 2025, she was elected Fellow of the European Respiratory Society (FERS) and Fellow of the Academy of Medical Sciences (FMedSci).
